Ilja E Shapiro1,2,3, Florian Huber1,2,3, Justine Michaux1,2,3

  • 1Department of Oncology, University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Nature communications
|August 7, 2025
PubMed
概括

通过改善新抗原检测,NeoDiscMS增强了个性化癌症免疫治疗. 这种基于质谱的方法增加了从有限的样本中识别瘤特异性标的信心,有助于临床抗原发现.